| |
 |
|
Manufacturers are reviving their serialization plans
The pioneering firms that installed serialization and track-and-trace systems are being joined by a fast follower crowd, but an industry-wide commitment is still in the future
|
|
Aggregate Spending Rules Arrive, But Industry Is Still Gearing Up
The 'Sunshine Act' provisions of the Affordable Care Act require records to be kept . . .
|
|
Drug Shortages Continue To Rise, With No Near-Term Resolution
A combination of regulatory processes and business practices are worsening an already-bad drug shortage situation . . .
|
|
Google Prepares for a Possible $500-Million Penalty for Illegal Online Pharmacy Advertising, Says WSJ
Dispute with US DoJ highlights role of NABP's Verified Internet Pharmacy Practice Sites (VIPPS) programs . . .
|
|
Aggregate Spend Laws: Here Comes the Sun
The industry is far from ready when it comes to collecting, aggregating, cleansing and disclosing data about regulated financial transactions with doctors and hospitals . . .
|
|
How REMS Affect Pharmaceutical Distribution Processes and Partners
First-ever study of the impact of REMS on supply chains finds that collaboration is a critical requirement . . .
|
|
Google Prepares for a Possible $500-Million Penalty for Illegal Online Pharmacy Advertising, Says WSJ
Dispute with US DoJ highlights role of NABP's Verified Internet Pharmacy Practice Sites (VIPPS) programs . . .
|
|
FDA's Social Media Enforcement: Emerging Rules of Engagement
The Food and Drug Administration (FDA) and Federal Trade Commission (FTC) have signaled that social media marketing is a priority . . .
|
|
FDA Opened 72 New Counterfeit Cases in 2010--a New Record
Caseload reinforces concerns over illegal trade and distribution of pharmaceuticals . . .
|
|
Adverse Event Reporting: At the Front Lines of Drug Safety
Industry and regulators are taking steps to revolutionize the basic regulatory function of collecting and analyzing adverse medical events . . .
|
|
|
|
|
